Genetic European Variation in Disease (GEUVADIS) Consortium

At a Glance
  • Status: Completed Consortium
  • Year Launched: 2011
  • Initiating Organization: European Commission Seventh Framework Programme (FP7)
  • Initiator Type: Government
  • No disease focus
  • Location: Europe

Abstract

The Genetic European Variation in Disease (GEUVADIS) consortium aims to develop standards on medical genome sequencing, creating a resource for European researchers to develop and test new hypotheses on the genetic basis of disease.

Mission

An increasing number of research centers in Europe have access to sequencing technologies, in-house or through regional, national and international infrastructures, but storing, disseminating and analyzing the large amount of data produced generate major challenges. Funded by the European Commission’s Seventh Framework Programme (FP7), the Genetic European Variation in Disease (GEUVADIS) consortium aims to develop standards on medical genome sequencing, creating a resource for European researchers to develop and test new hypotheses on the genetic basis of disease.  

The GEUVADIS Consortium aims to developing standards for:

Structure & Governance

The partners are all involved in international sequencing initiatives (1000 GP, ICGC), EU and other international projects (ENGAGE, GEN2PHEN, ENCODE, TECHGENE ), bio-banking activities (BBMRI), data sharing initiatives (ELIXIR), and the European Sequencing and Genotyping Infrastructure (ESGI), ensuring tight collaborations.

Sponsors & Partners

Bertero, Michela (Scientific Officer)
Tel.: +34 93 3160257
Fax: +34 93 3969983
E-mail

FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA
Spain


Last Updated: 04/18/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.